Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MAGNOLIA DIAGNOSTICS, LLC

NPI: 1922551399 · DALLAS, TX 75205 · Clinical Pathology/Laboratory Medicine Physician · NPI assigned 08/02/2016

$3.68M
Total Medicaid Paid
133,221
Total Claims
93,122
Beneficiaries
20
Codes Billed
2019-01
First Month
2024-04
Last Month

Provider Details

Authorized OfficialBAINS, JOHN (PRESIDENT)
Parent OrganizationMAGNOLIA HEALTH, LLC
NPI Enumeration Date08/02/2016

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 6,326 $466K
2020 20,063 $198K
2021 53,653 $1.23M
2022 40,222 $1.35M
2023 12,213 $406K
2024 744 $32K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 26,907 20,434 $1.51M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 5,280 4,786 $700K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 21,567 17,613 $390K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 20,895 7,178 $208K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 13,909 6,382 $180K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 6,197 5,217 $145K
87631 2,616 1,989 $96K
87486 6,249 5,260 $71K
87640 6,432 5,409 $67K
87581 5,892 4,966 $65K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 945 879 $61K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 6,669 5,558 $58K
87541 5,851 4,927 $56K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,429 1,227 $32K
87582 330 288 $15K
87542 330 288 $15K
87506 42 37 $3K
87150 666 130 $1K
87634 913 455 $65.51
87481 102 99 $0.00